Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia

NCT07564453 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

101

Enrollment

OTHER

Sponsor class

Conditions

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Interventions

BIOLOGICAL: Blinatumomab
DRUG: Induction Chemotherapy
DRUG: Hyper-CVAD
PROCEDURE: Allogeneic hematopoietic stem cell transplantation
BIOLOGICAL: CAR-T cell therapy

Sponsor

The First Affiliated Hospital of Soochow University